Using long intravenous catheters for antimicrobial therapy
Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy: a Randomized Controlled Trial
NA · Sir Run Run Shaw Hospital · NCT06455228
This study tests whether using long intravenous catheters in different places on the body can make it safer and more comfortable for patients getting long-term antimicrobial treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sir Run Run Shaw Hospital (other) |
| Locations | 1 site (Hangzhou) |
| Trial ID | NCT06455228 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of long peripheral intravenous catheters (PIVCs) in patients receiving antimicrobial therapy, focusing on the effects of different insertion sites. The goal is to identify the optimal placement site that minimizes complications, extends catheter retention time, and reduces patient discomfort. By comparing outcomes based on various insertion locations, the study aims to provide evidence-based recommendations for clinicians. The research is particularly relevant for patients requiring prolonged intravenous treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who require intravenous antimicrobial therapy for at least one week during hospitalization.
Not a fit: Patients with a history of complications at the catheterization site or those planning to be discharged with a catheter may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient comfort and reduced complications associated with long-term intravenous antimicrobial therapy.
How similar studies have performed: While there may be studies on catheter placement, this specific approach focusing on long PIVCs in antimicrobial therapy is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ① estimated time of intravenous infusion ≥1 week; ② age: ≥18 years; ③ antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure \< 900 mOsm/L; and ④ patients were conscious and able to communicate normally; ⑤ the catheter-to-vessel ratio is less than 45%. Exclusion Criteria: * ① a history of radiotherapy, thrombosis, and trauma at the catheterization site and ② plans to discharge with a catheter during the study duration.
Where this trial is running
Hangzhou
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine — Hangzhou, China (RECRUITING)
Study contacts
- Principal investigator: Zhao Linfang — Sir Run Run Shaw Hospital
- Study coordinator: Zhao Linfang
- Email: 3193159@zju.edu.cn
- Phone: 13588819123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Antimicrobial